fentanyl has been researched along with Respiratory Tract Diseases in 4 studies
Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
Respiratory Tract Diseases: Diseases involving the RESPIRATORY SYSTEM.
Excerpt | Relevance | Reference |
---|---|---|
" Patients receiving ketamine with or without midazolam experienced fewer respiratory adverse events but more vomiting than the commonly used combination of midazolam and fentanyl." | 3.73 | Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs. ( Bajaj, L; Bothner, JP; Roback, MG; Wathen, JE, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kerker, A | 1 |
Hardt, C | 1 |
Schlief, HE | 1 |
Dumoulin, FL | 1 |
Roback, MG | 1 |
Wathen, JE | 1 |
Bajaj, L | 1 |
Bothner, JP | 1 |
Ionides, SP | 1 |
Weiss, MG | 1 |
Angelopoulos, M | 1 |
Myers, TF | 1 |
Handa, RJ | 1 |
Ourahma, S | 1 |
Marchetti, F | 1 |
Clergue, F | 1 |
Levron, JC | 1 |
Le Moing, JP | 1 |
Viars, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase 4, Prospective, Randomized, Double-blinded, Placebo-controlled Study Comparing Propofol vs. Midazolam Plus Propofol for Nonanesthesiologist Targeted Moderate Sedation in Outpatient Colonoscopy[NCT01428882] | Phase 4 | 135 participants (Actual) | Interventional | 2011-06-30 | Completed | ||
A Comparison of Dexmedetomidine Versus Propofol for Use in Intravenous Sedation[NCT03255824] | Phase 4 | 144 participants (Actual) | Interventional | 2018-03-20 | Completed | ||
Comparison of Ketamine Versus Co-Administration of Ketamine and Propofol for Procedural Sedation in a Pediatric Emergency Department[NCT01387139] | Phase 3 | 183 participants (Actual) | Interventional | 2011-01-31 | Completed | ||
US Guided Interscalene Block Compared With Sedation for Shoulder Dislocation Reduction in the ER[NCT03041506] | 90 participants (Anticipated) | Interventional | 2017-02-15 | Not yet recruiting | |||
Positive Imagery Therapy and the Incidence of Emergence Reactions With the Use of Ketamine[NCT04746079] | 180 participants (Anticipated) | Interventional | 2021-02-05 | Recruiting | |||
The Pharmacokinetics of Fentanyl in Intensive Care Patients[NCT02587273] | Phase 4 | 150 participants (Anticipated) | Interventional | 2015-10-31 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
"After completion of the procedure, the patient stood in the examination room monitored continuously by a nurse. When patients responded to normal verbal command, they were asked to sit up and were offered a drink. This was considered the early recovery time.~If they were able to stand unassisted by the bed and had stable hemodynamics parameters (saturation>90 % on room air and blood pressure and heart rate within 20 % of baseline), they were transferred to a locker room accompanied by a relative. The discharge criteria included ability to stand unassisted and tolerate clear liquids once dressed. Once a patient met discharge criteria, they were allowed to leave at their own discretion" (NCT01428882)
Timeframe: Up to 1 hour after colonoscopy
Intervention | minutes (Mean) | |
---|---|---|
Early recovery time | Discharge time | |
Midazolam Balanced Propofol Sedation | 6.8 | 10.4 |
Single-agent Propofol Sedation | 5.3 | 9.80 |
Assessment every two minutes of the level of sedation during the endoscopic procedure, rating it as minimal, moderate or deep. (NCT01428882)
Timeframe: Up to 1 hour after introduction of the colonoscope
Intervention | participants (Number) | |||
---|---|---|---|---|
Deep sedation at any point | Deep sedation at minute 4 | Deep sedation at minute 6 | Deep sedation at minute 8 | |
Midazolam Balanced Propofol Sedation | 22 | 10 | 12 | 10 |
Single-agent Propofol Sedation | 9 | 1 | 2 | 3 |
"Endoscopists and patients rated their satisfaction with sedation in a 10-cm visual analogue scale after discharge.The patients were contacted 24-48 h after the procedure to answer a questionnaire regarding if they remembered scope insertion or scope removal and willingness to repeat it with a similar protocol and rated their satisfaction and pain perception from 0 to 10. This phone survey was done by the nurse specifically making the measurements in the endoscopy room, who was blinded to the sedation regimen.~For the interpretation of results of the 0-10 point numerical scale, 0 stands for 'extremely dissatisfied with sedation level during the endoscopic procedure', whereas 10 stands for 'extremely satisfied with sedation level during the endoscopic procedure." (NCT01428882)
Timeframe: Up to 1 hour after colonoscopy for endoscopists and up to 48 hours for patients
Intervention | units on a scale (Mean) | |
---|---|---|
Endoscopist Satisfaction | Patient Satisfaction | |
Midazolam Balanced Propofol Sedation | 8.9 | 9.8 |
Single-agent Propofol Sedation | 8.4 | 9.5 |
The following events were considered complications of procedural sedation: a decline in oxygen saturation to less than 85 % longer than 30 s after increasing the oxygen flow rate to 5 L/min and transient propofol interruption, a heart rate less than 40 beats per minute and blood pressure less than 80/50 mmHg. Major complications were defined as need for mechanical ventilation or any cardiorespiratory event requiring anaesthesiologist assistance. (NCT01428882)
Timeframe: Up to two hours, including colonoscopy performance and recovery period
Intervention | participants (Number) | ||
---|---|---|---|
Transient oxygen desaturation | Bradycardia | Arterial Hypotension | |
Midazolam Balanced Propofol Sedation | 5 | 2 | 3 |
Single-agent Propofol Sedation | 5 | 1 | 2 |
Surgeon satisfaction is measured by the Cooperation Scale. Minimum score of 0 and maximum of 9. Higher indicates a worse outcome (i.e., discomfort and movement) (NCT03255824)
Timeframe: 15 minutes following surgery
Intervention | score on a scale (Mean) |
---|---|
Propofol Group | 2.07 |
Dexmedetomidine Group | 1.47 |
"To compare the differences in hemodynamic stability using a D/M combination compared to the MFP combination. (In this study, a deviation from baseline by 20% or greater will be considered clinically significant)~a. Change in blood pressure (NIBP) (change ≥ 20%) Blood pressure is presented as mean arterial pressure" (NCT03255824)
Timeframe: During the procedure, up to 40 minutes
Intervention | mm Hg (Mean) |
---|---|
Propofol Group | 78 |
Dexmedetomidine Group | 88 |
"To compare the differences in hemodynamic stability using a D/M combination compared to the MFP combination. (In this study, a deviation from baseline of both the blood pressure and heart rate by 20% or greater will be considered clinically significant)~a. Change in heart rate (change ≥ 20 BPM)" (NCT03255824)
Timeframe: During the procedure, up to 40 minutes
Intervention | beats per minute (Mean) |
---|---|
Propofol Group | 77 |
Dexmedetomidine Group | 62 |
"Visual Analog Scale was used to measure overall satisfaction with the IV sedation and memory of the procedure.~The minimum score is 0 (not satisfied at all) to a maximum score of 100 (completely satisfied).~A higher score is a better outcome." (NCT03255824)
Timeframe: 30 minutes following surgery
Intervention | score on a scale (Mean) |
---|---|
Propofol Group | 93.5 |
Dexmedetomidine Group | 86.6 |
"To assess whether a D/M combination increases postoperative recovery time when compared the MFP combination.~a. Time to ambulation (to recovery room) will be recorded" (NCT03255824)
Timeframe: After the procedure until ambulation, up to 20 minutes
Intervention | minutes (Mean) |
---|---|
Propofol Group | 10.8 |
Dexmedetomidine Group | 11.6 |
"To assess whether a D/M combination increases postoperative recovery time when compared the MFP combination.~a. Duration of procedure will be recorded" (NCT03255824)
Timeframe: During the procedure, up to 40 minutes
Intervention | MINUTES (Mean) |
---|---|
Propofol Group | 24.2 |
Dexmedetomidine Group | 22.1 |
"To assess whether a D/M combination increases postoperative recovery time when compared the MFP combination.~a. Time to discharge or virtual discharge (comparative statistic) - Aldrete score of ≥ 9 or pre-procedure score is met The minimum score is 0 and the maximum score is 10. A higher score indicates wakefulness, hemodynamically stable, and able to ambulate.~ii. All subjects are required to stay a minimum of 30 minutes after the end of the procedure. Therefore, at least two postoperative vital sign readings will be obtained. If the subject meets discharge criteria prior to 30 minutes, this time will be the virtual discharge time" (NCT03255824)
Timeframe: After the procedure until discharge, up to 45 minutes
Intervention | minutes (Mean) |
---|---|
Propofol Group | 26.5 |
Dexmedetomidine Group | 29.9 |
"To compare the groups regarding movement of the patient during the first injection of local anesthesia during the IVS at time of injection measured using the Behavioral Pain Scale - Non-Intubated patients.~The minimum value is 3 and the maximum value is 12. Higher scores mean a worse outcome (i.e., more pain and movement on injection)" (NCT03255824)
Timeframe: During the first injection of local anesthesia during surgery
Intervention | score on a scale (Mean) |
---|---|
Propofol Group | 3.9 |
Dexmedetomidine Group | 4.2 |
"To assess whether a D/M combination leads to a significant change in respiratory depression compared to the MFP combination.~a. Change in arterial oxygen saturation (as measured by pulse oximeter) i. number of events of ≤92%" (NCT03255824)
Timeframe: During the procedure, up to 40 minutes
Intervention | Saturation percent (Mean) |
---|---|
Propofol Group | 98.7 |
Dexmedetomidine Group | 98.9 |
"To assess whether a D/M combination leads to a significant change in respiratory depression compared to the MFP combination.~a. Change in respiratory rate (change ≥ 20%)" (NCT03255824)
Timeframe: During the procedure, up to 40 minutes
Intervention | breaths per minute (Mean) |
---|---|
Propofol Group | 18 |
Dexmedetomidine Group | 18 |
To compare the groups regarding the number of respiratory events requiring intervention, described as: Chin lift/jaw thrust, Tongue thrust, Yankauer suctioning, Positive pressure oxygen administration, Placement of an oral or nasal airway. (NCT03255824)
Timeframe: During surgery
Intervention | Participants (Count of Participants) |
---|---|
Propofol Group | 17 |
Dexmedetomidine Group | 2 |
"Surgeon satisfaction was measured by the surgeon grading the Operating Conditions scale.~The minimum value was 0 and the maximum was 3. 0=very poor, 1=poor, 2=fair, 3=good" (NCT03255824)
Timeframe: 15 minutes following surgery
Intervention | score on a scale (Mean) |
---|---|
Propofol Group | 2.8 |
Dexmedetomidine Group | 2.9 |
"Efficacy is defined as:~The patient does not have unpleasant recall of the procedure.~The patient did not experience sedation-related adverse events resulting in abandonment of the procedure or a permanent complication or an unplanned admission to the hospital or prolonged emergency department (ED) observation~The patient did not actively resist or require physical restraint for completion of the procedure. The need for minimal redirection of movements should not be considered as active resistance or physical restraint.~The procedure was successful" (NCT01387139)
Timeframe: After procedure is completed, on average less than 1 hour
Intervention | participants (Number) |
---|---|
Ketamine Alone | 97 |
Ketamine Co-Administered With Propofol | 81 |
Measured on a 10-point scale (1= least satisfied, 10= most satisfied) (NCT01387139)
Timeframe: After procedure is completed, on average less than 1 hour
Intervention | units on a scale (Median) |
---|---|
Ketamine Alone | 10 |
Ketamine Co-Administered With Propofol | 8 |
Measured on a 10-point scale (1= least satisfied, 10= most satisfied) (NCT01387139)
Timeframe: After procedure is completed, on average less than 1 hour
Intervention | units on a scale (1-10) (Median) |
---|---|
Ketamine Alone | 10 |
Ketamine Co-Administered With Propofol | 10 |
Measured on a 10-point scale (1= least satisfied, 10= most satisfied) (NCT01387139)
Timeframe: After procedure is completed, on average less than 1 hour
Intervention | units on a scale (Median) |
---|---|
Ketamine Alone | 9 |
Ketamine Co-Administered With Propofol | 8 |
Time until the patient has a Vancouver Sedation Recovery Scale Score of 18 or greater. (NCT01387139)
Timeframe: Once Vancouver Sedation Recovery Scale Score reaches 18 or greater, on average less than 1 hour
Intervention | minutes (Median) |
---|---|
Ketamine Alone | 44 |
Ketamine Co-Administered With Propofol | 43.5 |
We will record all adverse events during the sedation, and then perform a follow-up call to determine if any additional adverse events occured after discharge. (NCT01387139)
Timeframe: From enrollment through completion of follow-up, up to 7 days
Intervention | participants (Number) | |||
---|---|---|---|---|
Respiratory depression | Cardiovascular event | vomiting/retching | Unpleasant recovery reaction | |
Ketamine Alone | 12 | 1 | 21 | 4 |
Ketamine Co-Administered With Propofol | 15 | 0 | 18 | 2 |
2 trials available for fentanyl and Respiratory Tract Diseases
Article | Year |
---|---|
Plasma beta-endorphin concentrations and analgesia-muscle relaxation in the newborn infant supported by mechanical ventilation.
Topics: beta-Endorphin; Female; Fentanyl; Humans; Infant, Newborn; Male; Morphine; Muscle Relaxation; Pancur | 1994 |
[Peroperative perfusion of fentanyl or sufentanil: plasma concentrations and postoperative respiratory changes].
Topics: Adult; Aged; Female; Fentanyl; Humans; Infusions, Intravenous; Male; Middle Aged; Postoperative Comp | 1993 |
2 other studies available for fentanyl and Respiratory Tract Diseases
Article | Year |
---|---|
Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients.
Topics: Adult; Aged; Endoscopy, Gastrointestinal; Female; Fentanyl; Humans; Hypnotics and Sedatives; Male; M | 2010 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |
Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.
Topics: Adolescent; Adult; Analgesia; Analgesics; Cardiovascular Diseases; Child; Child, Preschool; Cohort S | 2005 |